RYBOQUIN
LIVE

Serial Number

79076310

Owner

EctoPharma Limited

Filing Date

Nov 6, 2009

Add to watchlist:

No watchlists yet
View on USPTO

RYBOQUIN Trademark

Serial Number: 79076310 • Registration: 3814835

RYBOQUIN is a trademark filed by EctoPharma Limited on November 6, 2009. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

EctoPharma Limited (2 trademarks)

Ettrick Riverside
Selkirk TD75EB , GB

Entity Type: 03

Ryboquin Company Limited (2 trademarks)

Ettrick Riverside,

Entity Type: 98

Trademark Details

Filing Date

November 6, 2009

Registration Date

July 6, 2010

Published for Opposition

April 20, 2010

Cancellation Date

February 10, 2017

Goods & Services

Pharmaceutical preparations, namely, ligase inhibitors for the treatment of cancer

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Apr 23, 2024 NREP
INTERNATIONAL REGISTRATION RENEWED
Mar 2, 2020 RNWL
NEW REPRESENTATIVE AT IB RECEIVED
Apr 24, 2019 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
May 11, 2018 FINV
TOTAL INVALIDATION PROCESSED BY THE IB
Nov 17, 2017 INNT
GENERIC MADRID TRANSACTION CREATED
Oct 11, 2017 XXCR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 10, 2017 INTR
CANCELLED SECTION 71
Feb 10, 2017 C71T
CHANGE OF OWNER RECEIVED FROM IB
Mar 27, 2015 CHLD
NEW REPRESENTATIVE AT IB RECEIVED
Aug 28, 2014 NREP
REGISTERED-PRINCIPAL REGISTER
Jul 6, 2010 R.PR
PUBLISHED FOR OPPOSITION
Apr 20, 2010 PUBO
NOTICE OF PUBLICATION
Mar 31, 2010 NPUB
CHANGE OF NAME/ADDRESS REC'D FROM IB
Mar 26, 2010 ADCH
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 17, 2010 PREV
ASSIGNED TO LIE
Mar 17, 2010 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 28, 2010 CNSA
ASSIGNED TO EXAMINER
Feb 21, 2010 DOCK
ASSIGNED TO EXAMINER
Feb 12, 2010 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 5, 2010 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 30, 2009 NWOS
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Dec 28, 2009 LIMS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 24, 2009 REPR